Status:

COMPLETED

Mitral Valve Regurgitation Quantification From 3D Color Doppler Ultrasound - Standard of Care Data Collection

Lead Sponsor:

Philips Electronics Nederland B.V. acting through Philips CTO organization

Conditions:

Mitral Valve Regurgitation of Any Grade

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

The study primarily aims to collect standard of care clinical data in a wide spectrum of simple to complex mitral valve regurgitation (MVR) cases to validate a post-processing stand-alone software pro...

Eligibility Criteria

Inclusion

  • both genders
  • age between 18 and 85 years old (adult, senior)
  • sinus rhythm
  • hHemodynamic stable
  • mitral valve regurgitation (MVR) of any grade i.e., from mild to severe as determined by assessment of a qualifying TransThoracic Echocardiography (TTE) exam at Saint-Luc University Hospital
  • scheduled for TransEsophageal Echocardiography (TEE) at Saint-Luc University Hospital, as part of the subject's routine standard of care
  • subjects has functional capacity to give written informed consent

Exclusion

  • pregnancy
  • subject lacks functional capacity to give written informed consent belongs to a vulnerable population per investigator's judgment or subject has any kind of disorder that compromises his/her ability to give written informed consent and/or to comply with study procedures
  • Among the120 subjects, there will be three (3) sub-groups as follows:
  • a first sub-group (A) of 50 subjects with all inclusion criteria and none of the exclusion criteria
  • a second sub-group (B) of 50 subjects with additional inclusion criterion: scheduled for cardiac Magnetic Resonance (cMR), as part of the subject's routine standard of care
  • a third sub-group (C) of 20 subjects with additional inclusion criterion: scheduled for MitraClip transcatheter mitral valve repair (MitraClip) procedure as part of the subject's routine standard of care

Key Trial Info

Start Date :

August 22 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2019

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT03286088

Start Date

August 22 2017

End Date

December 31 2019

Last Update

October 27 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Saint Luc University Hospital

Brussels, Belgium, 1200